作者于1991～1992年冬季在德国对不同年龄和不同疫苗接种史志愿者对三价流感裂解疫苗的抗体应答作了评价。 所用的疫苗由世界卫生组织(WHO)推荐的病毒株制成,含A/新加坡/6/86(H1N1)、A/北京/353/89(H3N2)和B/山形/16/88血凝素各15μg,疫苗剂量为0.5ml。将296名志愿者分成5组,A组:34名健康青年;B组:87名健康中年人(其中23人在1990年接种过疫苗);C组:70名老年人(其中21人在1990年接种过疫苗);D组:47例 In the winter of 1991-1992, the authors evaluated the antibody response to trivalent flu-splitting vaccines in volunteers of different ages and in different vaccinations in Germany. The vaccine used was made by a strain of virus recommended by the World Health Organization (WHO) containing A / Singapore / 6/86 (H1N1), A / Beijing / 353/89 (H3N2) and B / Yamagata / 16/88 hemagglutinin Each 15 μg vaccine dose of 0.5 ml. 296 volunteers were divided into 5 groups, Group A: 34 healthy youths; Group B: 87 healthy middle-aged people (23 vaccinated in 1990); Group C: 70 elderly Vaccinated in 1990); Group D: 47 cases